This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Feb 1;60(2):489-491.

doi: 10.1093/rheumatology/keaa675.

Rituximab for the treatment of systemic sclerosis-interstitial lung disease

Michael Hughes¹, Christopher P Denton², Dinesh Khanna³

Affiliations

Affiliations

¹ Department of Rheumatology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK.
² Department of Rheumatology, Royal Free Hospital, University College London, London, UK.
³ Scleroderma Program, University of Michigan, Ann Arbor, MI, USA.

PMID: 33244601
DOI: 10.1093/rheumatology/keaa675

Comment

Rituximab for the treatment of systemic sclerosis-interstitial lung disease

Michael Hughes et al. Rheumatology (Oxford). 2021.

. 2021 Feb 1;60(2):489-491.

doi: 10.1093/rheumatology/keaa675.

Authors

Michael Hughes¹, Christopher P Denton², Dinesh Khanna³

Affiliations

¹ Department of Rheumatology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK.
² Department of Rheumatology, Royal Free Hospital, University College London, London, UK.
³ Scleroderma Program, University of Michigan, Ann Arbor, MI, USA.

PMID: 33244601
DOI: 10.1093/rheumatology/keaa675

No abstract available

PubMed Disclaimer

Comment on

Rituximab in the treatment of systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis.
Goswami RP, Ray A, Chatterjee M, Mukherjee A, Sircar G, Ghosh P. Goswami RP, et al. Rheumatology (Oxford). 2021 Feb 1;60(2):557-567. doi: 10.1093/rheumatology/keaa550. Rheumatology (Oxford). 2021. PMID: 33164098

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Medical
- MedlinePlus Health Information